Annual Accounts Receivable
N/A
December 31, 2023
Summary
- CANF annual accounts receivable is not available.
Performance
CANF Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
N/A
June 30, 2024
Summary
- CANF quarterly accounts receivable is not available.
Performance
CANF Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
CANF Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CANF Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Can-Fite BioPharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2017 | - | $3.61 M(+7.6%) |
| Jun 2017 | - | $3.35 M(+38.7%) |
| Mar 2017 | - | $2.42 M(>+9900.0%) |
| Dec 2016 | $21.80 K(-64.8%) | - |
| Dec 2016 | - | $21.80 K(-98.8%) |
| Sep 2016 | - | $1.75 M(+1.9%) |
| Jun 2016 | - | $1.71 M(+24.2%) |
| Mar 2016 | - | $1.38 M(+2124.0%) |
| Dec 2015 | $62.00 K(-92.9%) | - |
| Dec 2015 | - | $62.00 K(-91.2%) |
| Sep 2015 | - | $705.80 K(-6.6%) |
| Jun 2015 | - | $755.60 K(-16.5%) |
| Mar 2015 | - | $905.00 K(+3.1%) |
| Dec 2014 | $877.50 K | - |
| Dec 2014 | - | $877.50 K(+27.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | - | $690.30 K(-12.8%) |
| Jun 2014 | - | $791.20 K(-6.1%) |
| Mar 2014 | - | $842.40 K(+1360.0%) |
| Dec 2013 | $57.70 K(-86.9%) | $57.70 K(-87.3%) |
| Sep 2013 | - | $452.60 K(-0.8%) |
| Jun 2013 | - | $456.10 K(-27.3%) |
| Mar 2013 | - | $627.60 K(+43.0%) |
| Dec 2012 | $439.00 K(+636.6%) | - |
| Dec 2012 | - | $439.00 K(-25.4%) |
| Sep 2012 | - | $588.70 K(-24.7%) |
| Jun 2012 | - | $781.70 K(-13.5%) |
| Mar 2012 | - | $903.70 K(+1416.3%) |
| Dec 2011 | $59.60 K | - |
| Dec 2011 | - | $59.60 K(-92.5%) |
| Sep 2011 | - | $799.50 K |
FAQ
- What is the all time high annual accounts receivable for Can-Fite BioPharma?
- What is the all time high quarterly accounts receivable for Can-Fite BioPharma?
What is the all time high annual accounts receivable for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual accounts receivable is $877.50 K
What is the all time high quarterly accounts receivable for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly accounts receivable is $3.61 M